<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Biallelic MutY human homologue (MUTYH) germline mutations predispose to recessively inherited <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">adenomatous polyposis</z:e>, designated MUTYH-associated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> (MAP), and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The hotspot mutations p.Y179C and p.G396D account for the majority of pathogenic variants of MUTYH in Caucasians </plain></SENT>
<SENT sid="2" pm="."><plain>Our aim was to evaluate the prevalence of MUTYH mutations in a prospective cohort of unselected patients with different colorectal diseases </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: The hotspot mutations p.Y179C and p.G396D were genotyped in 352 consecutive patients undergoing colonoscopy at our tertiary referral centre </plain></SENT>
<SENT sid="4" pm="."><plain>Exons 2-14 were sequenced in hotspot mutation carriers to exclude additional variants </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Overall, we identified five heterozygous p.Y179C mutations and three heterozygous p.G396D mutations in seven hotspot mutation carriers (risk allele frequencies 0.7% and 0.4%, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>Two of these hotspot mutation carriers harboured a heterozygous p.Q338H variant, which is of uncertain clinical significance, on the other allele </plain></SENT>
<SENT sid="7" pm="."><plain>Three individuals were biallelic MUTYH variant carriers (p.Y179C/p.G382D: typical MAP; p.Y179C/p.Q338H: atypical MAP with <z:hpo ids='HP_0003584'>late onset</z:hpo> and lower <z:mpath ids='MPATH_491'>polyp</z:mpath> burden; p.G382D/p.Q338H: <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>), and four subjects were monoallelic mutation carriers </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: MUTYH-associated disease, and hence genetic counselling and MUTYH genetic testing, should be considered in the clinical routine of an endoscopy unit, but the wide range of phenotypes represents a challenge for patient identification </plain></SENT>
<SENT sid="9" pm="."><plain>The clinical significance of p.Q338H should be evaluated in future case-control studies because compound heterozygotes for pathogenic mutations and p.Q338H may be at increased risk for mild <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, MUTYH should be assessed as a potential susceptibility gene for the development of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in future </plain></SENT>
</text></document>